American Board Of Nuclear Medicine Inc
American Board Of Nuclear Medicine Inc consistently operates with a surplus and reports no officer compensation.
EIN: 132690306 · Saint Louis, MO · NTEE: G9XZ · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $2.2M |
| Total Expenses | $967K |
| Program Spending | 90% |
| CEO/Top Officer Pay | $5 |
| Net Assets | $4.5M |
| Transparency Score | 95/100 |
Is American Board Of Nuclear Medicine Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
American Board Of Nuclear Medicine Inc directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About American Board Of Nuclear Medicine Inc
American Board Of Nuclear Medicine Inc (EIN: 132690306) is a nonprofit organization based in Saint Louis, MO, classified under NTEE code G9XZ. The organization reported total revenue of $2.2M and total assets of $4.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of American Board Of Nuclear Medicine Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
American Board Of Nuclear Medicine Inc is a mid-size nonprofit that has been operating for 54 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 2.7%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $1.1M |
| Total Expenses | $967K |
| Surplus / Deficit | +$109K |
| Total Assets | $4.7M |
| Total Liabilities | $146K |
| Net Assets | $4.5M |
| Operating Margin | 10.1% |
| Debt-to-Asset Ratio | 3.1% |
| Months of Reserves | 57.7 months |
Financial Health Grade: A
In 2023, American Board Of Nuclear Medicine Inc reported a surplus of $109K with revenue exceeding expenses, holds 57.7 months of operating reserves (strong position), has a debt-to-asset ratio of 3.1% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), American Board Of Nuclear Medicine Inc's revenue has grown at a compound annual growth rate (CAGR) of 2.7%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +4.5% | -5.3% | +11.3% |
| 2022 | -6.9% | +21.3% | -13.5% |
| 2021 | +7.8% | +3.6% | +10.3% |
| 2020 | -10.2% | -5.4% | +12.1% |
| 2019 | +5.9% | -5.4% | +16.3% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 1972 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates American Board Of Nuclear Medicine Inc with a Mission Score of 95 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 90%
- fundraising: 0%
According to IRS 990 filings, American Board Of Nuclear Medicine Inc allocates its expenses as follows: admin: 10%, programs: 90%, fundraising: 0%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $109K, with revenue exceeding expenses.
- Debt-to-asset ratio: 3.1%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that no officers receive compensation from the organization. This is highly unusual for an organization of its size with assets nearing $5 million and annual revenues over $1 million, suggesting a volunteer-led or externally compensated leadership structure.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of American Board Of Nuclear Medicine Inc's IRS 990 filings:
- Unclear how leadership is compensated given 0% officer compensation reported, potentially indicating an undisclosed compensation structure or reliance on external support.
Strengths
The following positive indicators were identified for American Board Of Nuclear Medicine Inc:
- Consistent financial surpluses, demonstrating sound fiscal management (e.g., $109,009 surplus in 2023).
- Strong asset growth over the past decade, indicating long-term financial health (assets grew from $3.1M in 2014 to $4.6M in 2023).
- Very low liabilities relative to assets, suggesting minimal financial risk (e.g., liabilities were $146,070 against $4,652,253 in assets in 2023).
- Reported 0% officer compensation, indicating a strong commitment to directing funds towards the mission rather than executive salaries.
- Stable revenue streams, consistently around $1 million annually, providing predictable funding for operations.
Frequently Asked Questions about American Board Of Nuclear Medicine Inc
Is American Board Of Nuclear Medicine Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, American Board Of Nuclear Medicine Inc (EIN: 132690306) some concerns. Mission Score: 95/100. 1 red flag identified, 5 strengths noted.
How does American Board Of Nuclear Medicine Inc spend its money?
American Board Of Nuclear Medicine Inc directs 90% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to American Board Of Nuclear Medicine Inc tax-deductible?
American Board Of Nuclear Medicine Inc is registered as a tax-exempt nonprofit (EIN: 132690306). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the American Board Of Nuclear Medicine Inc CEO make?
American Board Of Nuclear Medicine Inc's highest-compensated officer earns $5 annually. The organization reported $2.2M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
How does American Board Of Nuclear Medicine Inc compare to similar nonprofits?
With a transparency score of 95/100 (Excellent), American Board Of Nuclear Medicine Inc is above average for NTEE category G9XZ nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is American Board Of Nuclear Medicine Inc located?
American Board Of Nuclear Medicine Inc is headquartered in Saint Louis, Missouri and files with the IRS under EIN 132690306. It is classified under NTEE code G9XZ.
How many years of IRS 990 filings does American Board Of Nuclear Medicine Inc have?
American Board Of Nuclear Medicine Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $2.2M in total revenue.
How does the American Board Of Nuclear Medicine Inc manage to operate without officer compensation?
The filings consistently show 0% officer compensation, which could imply that leadership roles are filled by volunteers, or that compensation for these roles is covered by an affiliated entity, or through other non-reportable means. Further investigation into their operational model would be needed to fully understand this structure.
What is the primary use of the organization's consistent revenue surplus?
The consistent revenue surplus, such as the $109,009 surplus in 2023 ($1,076,464 revenue - $967,455 expenses), appears to contribute to the growth of the organization's assets, which increased from $3,123,320 in 2014 to $4,652,253 in 2023. This suggests reinvestment into the organization's long-term stability and capacity.
Is the American Board Of Nuclear Medicine Inc financially stable?
Yes, the organization appears financially stable. It consistently generates more revenue than expenses, maintains a healthy and growing asset base (e.g., $4,652,253 in assets in 2023), and has relatively low liabilities ($146,070 in 2023), indicating a strong financial position.
Filing History
IRS 990 filing history for American Board Of Nuclear Medicine Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), American Board Of Nuclear Medicine Inc's revenue has grown by 36.9%, moving from $786K to $1.1M. Total assets increased by 110.5% over the same period, from $2.2M to $4.7M. Total functional expenses rose by 32.4%, from $731K to $967K. In its most recent filing year (2023), American Board Of Nuclear Medicine Inc reported a surplus of $109K, with revenue exceeding expenses. The organization holds $146K in liabilities against $4.7M in assets (debt-to-asset ratio: 3.1%), resulting in net assets of $4.5M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $1.1M | $967K | $4.7M | $146K | — | — |
| 2022 | $1.0M | $1.0M | $4.2M | $137K | — | View 990 |
| 2021 | $1.1M | $842K | $4.8M | $107K | — | View 990 |
| 2020 | $1.0M | $813K | $4.4M | $120K | — | View 990 |
| 2019 | $1.1M | $859K | $3.9M | $71K | — | View 990 |
| 2018 | $1.1M | $908K | $3.4M | $80K | — | View 990 |
| 2017 | $803K | $821K | $3.5M | $82K | — | View 990 |
| 2016 | $1.0M | $924K | $3.3M | $53K | — | View 990 |
| 2015 | $1.1M | $925K | $3.1M | $83K | — | View 990 |
| 2014 | $956K | $881K | $3.1M | $22K | — | View 990 |
| 2013 | $1.1M | $788K | $3.0M | $7K | — | View 990 |
| 2012 | $1.1M | $756K | $2.6M | $21K | — | View 990 |
| 2011 | $786K | $731K | $2.2M | $46K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $1.1M, expenses of $967K, and assets of $4.7M (revenue +4.5% year-over-year).
- 2022: Revenue of $1.0M, expenses of $1.0M, and assets of $4.2M (revenue -6.9% year-over-year).
- 2021: Revenue of $1.1M, expenses of $842K, and assets of $4.8M (revenue +7.8% year-over-year).
- 2020: Revenue of $1.0M, expenses of $813K, and assets of $4.4M (revenue -10.2% year-over-year).
- 2019: Revenue of $1.1M, expenses of $859K, and assets of $3.9M (revenue +5.9% year-over-year).
- 2018: Revenue of $1.1M, expenses of $908K, and assets of $3.4M (revenue +34.4% year-over-year).
- 2017: Revenue of $803K, expenses of $821K, and assets of $3.5M (revenue -20.2% year-over-year).
- 2016: Revenue of $1.0M, expenses of $924K, and assets of $3.3M (revenue -8.4% year-over-year).
- 2015: Revenue of $1.1M, expenses of $925K, and assets of $3.1M (revenue +14.9% year-over-year).
- 2014: Revenue of $956K, expenses of $881K, and assets of $3.1M (revenue -16.3% year-over-year).
- 2013: Revenue of $1.1M, expenses of $788K, and assets of $3.0M (revenue +3.5% year-over-year).
- 2012: Revenue of $1.1M, expenses of $756K, and assets of $2.6M (revenue +40.4% year-over-year).
- 2011: Revenue of $786K, expenses of $731K, and assets of $2.2M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for American Board Of Nuclear Medicine Inc:
Data Sources and Methodology
This transparency report for American Board Of Nuclear Medicine Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.